Formononetin ameliorates muscle atrophy by regulating myostatin-mediated PI3K/Akt/FoxO3a pathway and satellite cell function in chronic kidney disease.
Formononetin ameliorates muscle atrophy by regulating myostatin-mediated PI3K/Akt/FoxO3a pathway and satellite cell function in chronic kidney disease.
复制标题
芒柄花素通过调节慢性肾脏病中肌生长抑制素介导的 PI3K/Akt/FoxO3a 通路和卫星细胞功能来改善肌肉萎缩
DOI:
10.1111/jcmm.16238
复制
发表时间:
2021-03
影响因子:
5.3
通讯作者:
Wei L
中科院分区:
文献类型:
--
作者:
Liu L;Hu R;You H;Li J;Liu Y;Li Q;Wu X;Huang J;Cai X;Wang M;Wei L
Muscle atrophy is a common complication in chronic kidney disease (CKD). Inflammation and myostatin play important roles in CKD muscle atrophy. Formononetin (FMN), which is a major bioactive isoflavone compound in Astragalus membranaceus, exerts anti‐inflammatory effects and the promotion of myogenic differentiation. Our study is based on myostatin to explore the effects and mechanisms of FMN in relation to CKD muscle atrophy. In this study, CKD rats and tumour necrosis factor α (TNF‐α)‐induced C2C12 myotubes were used for in vivo and in vitro models of muscle atrophy. The results showed that FMN significantly improved the renal function, nutritional status and inflammatory markers in CKD rats. Values for bodyweight, weight of tibialis anterior and gastrocnemius muscles, and cross‐sectional area (CSA) of skeletal muscles were significantly larger in the FMN treatment rats. Furthermore, FMN significantly suppressed the expressions of MuRF‐1, MAFbx and myostatin in the muscles of CKD rats and the TNF‐α‐induced C2C12 myotubes. Importantly, FMN significantly increased the phosphorylation of PI3K, Akt, and FoxO3a and the expressions of the myogenic proliferation and differentiation markers, myogenic differentiation factor D (MyoD) and myogenin in muscles of CKD rats and the C2C12 myotubes. Similar results were observed in TNF‐α‐induced C2C12 myotubes transfected with myostatin‐small interfering RNA (si‐myostatin). Notably, myostatin overexpression plasmid (myostatin OE) abolished the effect of FMN on the phosphorylation of the PI3K/Akt/FoxO3a pathway and the expressions of MyoD and myogenin. Our findings suggest that FMN ameliorates muscle atrophy related to myostatin‐mediated PI3K/Akt/FoxO3a pathway and satellite cell function.
登录
查看更多内容
影响因子:
3.6
作者:
Luo, Liyu;Zhou, Junyi;Gao, Wenyuan
通讯作者:
Gao, Wenyuan
影响因子:
3.8
作者:
Ribeiro Braosi, Ana Paula;de Souza, Cleber Machado;Trevilatto, Paula Cristina
通讯作者:
Trevilatto, Paula Cristina
影响因子:
3.2
作者:
Li, Yuanfei;Zhang, Faya;Zhang, Hui
通讯作者:
Zhang, Hui
影响因子:
4.2
作者:
Ibrahim, Salwa;El Salamony, Omima
通讯作者:
El Salamony, Omima
影响因子:
2.6
作者:
Matsakas, Antonios;Otto, Anthony;Patel, Ketan
通讯作者:
Patel, Ketan